We thank the reviewer for reading our manuscript closely and pointing out our oversight. As you indicated, we did not find any significance difference in 2D in Figure 1A and have corrected the results section as follows.
It was also of interest to compare the expression of NR2F1 between primary and metastatic breast cancer, but there was no difference observed in the NR2F1 expression between both groups (Figure 3E).